We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Immunocore Initiates Phase IIa Clinical Trial for IMCgp100 in Melanoma

News   Nov 04, 2013

 
Immunocore Initiates Phase IIa Clinical Trial for IMCgp100 in Melanoma
 
 
 

RELATED ARTICLES

Patient-specific Organoid Models Appendix Cancer Treatment

News

Patient-specific tumor ‘organoid’ models have been developed, to identify the most effective treatment for each tumor.

READ MORE

A Way to Visualize a Genetic Mutation

News

A team of scientists has developed a method that yields, for the first time, visualization of a gene amplifications and deletions known as copy number variants in single cells.

READ MORE

Drug Candidate Against a Forgotten Tropical Disease

News

Researchers from the Swiss Tropical and Public Health Institute together with colleagues from Singapore have discovered a highly effective compound against Buruli ulcer which has the potential to become a powerful alternative to the existing treatment options.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE